Urinary retention resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(121 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__


{{WikiDoc CMG}}; {{AE}}  
{{WikiDoc CMG}}; {{AE}} [[User:Kanwal Khamuani|Kanwal Khamuani]]
 
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0" ;
|-
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align="center" |{{fontcolor|#2B3B44|Urinary retention Resident Survival Guide Microchapters}}
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Overview|Overview]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Causes|Causes]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Urinary Retention in Women|Urinary retention in women]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Urinary Retention in Men|Urinary Retention in Men]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Diagnosis|Diagnosis]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Treatment|Treatment]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Do's|Do's]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Urinary retention resident survival guide#Don'ts|Don'ts]]
|}
{{SK}}
{{SK}}
==Overview==
==Overview==
[[Urinary retention]] can be defined as an inability to pass urine or incomplete emptying of the [[bladder]]. It is one of the most common presenting complaint encountered in emergency department. It can be acute or chronic. It is commonly seen in males as compared to females due to [[benign prostate hyperplasia]].
[[Urinary retention]] is defined as an inability to pass [[urine]], or incomplete emptying of the [[bladder]]. It is one of the most common presenting complaints encountered in the [[emergency department]], and can be acute or chronic. It is commonly seen in [[males]] as compared to [[females]] due to [[benign prostate hyperplasia]]. If undiagnosed or left untreated, this condition can be life-threatening as it may lead to [[kidney]] damage and severe [[urosepsis]]. Acute urinary retention can be extremely uncomfortable, and is initially managed by urethral or suprapubic  [[catheterization]]. Chronic [[urinary retention]] is often asymptomatic,  not easily identified, and is linked to increased [[post void]] residual volume. A complete detailed history about current prescription, [[over the counter]] and [[herbal medications]] is necessary along with focused [[physical examination]] that must include [[neurological]] evaluation.


==Causes==
==Causes==
===Life Threatening Causes===
===Urinary Retention in Women===
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Urinary retention is overall very rare in women and can be acute or chronic. Common causes include:
* [[Life threatening cause 1]]
<ref name="pmid30277739">{{cite journal| author=Serlin DC, Heidelbaugh JJ, Stoffel JT| title=Urinary Retention in Adults: Evaluation and Initial Management. | journal=Am Fam Physician | year= 2018 | volume= 98 | issue= 8 | pages= 496-503 | pmid=30277739 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30277739  }} </ref>
* [[Life threatening cause 2]]
 
* [[Life threatening cause 3]]
*Nerve injury during surgery-For example [[Episiotomy]]-[[postoperative]]
*Medications-[[Atropine]], [[Glycopyrrolate]], [[Bupivacaine]]
*Fowler's syndrome<ref name="pmid20877602">{{cite journal| author=Mevcha A, Drake MJ| title=Etiology and management of urinary retention in women. | journal=Indian J Urol | year= 2010 | volume= 26 | issue= 2 | pages= 230-5 | pmid=20877602 | doi=10.4103/0970-1591.65396 | pmc=2938548 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20877602  }} </ref>
*Obstructive causes-Vaginal [[hematoma]], Vaginal [[packing]], [[Sling]], [[Foreign body]], Pelvic organ [[prolapse]], [[Urethral]] injury
 
===Urinary Retention in Men===
Urinary retention is more common in males, with a male to female ratio of 13:1.


===Common Causes===
'''Causes of Acute urinary retention in men'''<br>
* [[Common cause 1]]
❑ Obstructive causes
* [[Common cause 2]]
 
* [[Common cause 3]]
:❑ [[Benign Prostate Hyperplasia]]
* [[Common cause 4]]
:❑ [[Prostate]] or [[Bladder]] [[Carcinoma]]
* [[Common cause 5]]
:❑ [[Constipation]]
:❑ [[Urolithiasis]]
:❑ [[Urethral Stricture]]
:❑ [[Phimosis]] or [[Paraphimosis]]
 
❑ Infectious Causes
 
:❑ [[Prostatitis]]
:❑ [[Urethritis]]
:❑ [[Genital herpes]]
 
❑ Neurological Causes<br>
 
:❑ [[stroke]]
:❑ [[spinal cord]] injury
:❑ [[Demyelinating]] disorders-[[Guillain barre syndrome]], [[diabetic neuropathy]], [[Multiple sclerosis]].
 
[[Detrusor]] [[Muscle]] Dysfunction<br>
❑ Medications<br>
 
:❑ [[Sympathomimetic]] [[alpha adrenergic]] agents-[[Phenylephrine]]
:❑ [[Sympathomimetic]] [[beta adrenergic]] agents-[[Isoproterenol]]
:❑ [[Antidepressants]]-[[Amitriptyline]],[[Imipramine]]
:❑ [[Antiarrhythmics]]-[[Quinidine]], [[procainamide]], [[Disopyramide]]
:❑ [[Anticholinergics]]-Atropine, [[oxybutynin]], [[glycopyrrolate]]
:❑ [[Antiparkinsonian]] agents-[[Amantadine]], [[trihexyphenidyl]],[[levadopa]], [[bromocriptine]]
:❑ [[Antipsychotics]]-Haloperidol, [[fluphenazine]]
:❑ [[Hormonal]] agents-estrogen, [[progesterone]], [[testosterone]]
:❑ [[Antihistamines]]-diphenhydramine, hydroxysine
:❑ [[Antihypertensives]]-Hydralazine,nifedipine
:❑ Others-indomethacin, morphine, dopamine, amphetamines<br>
 
'''Causes of Chronic urinary retention in Men'''<br>
❑ Neurological Causes<br>
 
:❑ [[Diabetic neuropathy]]
:❑ [[peripheral neuropathy]]
:❑ [[Spinal]] injury
 
❑ [[Detrusor]] [[Muscle]] Dysfunction<br>


==Diagnosis==
==Diagnosis==
Shown below is an algorithm summarizing the diagnosis of <nowiki>[[disease name]]</nowiki> according the the [...] guidelines.
A detailed history and a thorough physical examination may help in diagnosing the cause behind urinary retention.
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree/start}}
{{familytree | | | | A01 | | | A01= }}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | | | | | | | | | | | | | A10 | | | | | A10= <div style="float: left; text-align: left; width: 15em; padding:1em;">'''History''' <br>
{{familytree | | | | |!| | | | }}
❑ [[Inquire about lower urinary symptoms|<span style="color:white;">inquire about lower urinary symptoms</span>]]
{{familytree | | | | B01 | | | B01= }}
:❑ [[how often patient has this difficulty in voiding|<span style="color:white;">how often patient has this difficulty in voiding</span>]]
{{familytree | | |,|-|^|-|.| | }}
:❑ [[how frequently patient voids in a single day|<span style="color:white;">how frequently patient void in a single day</span>]]
{{familytree | | C01 | | C02 | C01= | C02= }}
:❑ [[how frequently patient has a weak stream of urine|<span style="color:white;">how frequently patient has weak stream of urine</span>]]
:❑ [[ask patient about difficulty holding urine|<span style="color:white;">ask patient about difficulty holding urine</span>]]
:❑ [[ask about nocturia|<span style="color:white;">ask about nocturia</span>]]
:❑ [[Does the patient have to strain or push to urinate|<span style="color:white;">Does the patient have to strain or push to urinate</span>]]
:❑ [[ask about dribbling after passing urine|<span style="color:white;">ask about dribling after passing urine</span>]]<br>
❑ [[inquire about past history of prostate disease or cancer|<span style="color:white;">Inquire about past history of prostate disease or cancer</span>]] <br>
❑ [[Inquire about history of stones, STIs, radiation exposure|<span style="color:white;">Inquire about history of stones, STIs, radiation exposure</span>]] <br>
❑ [[Other symptoms|<span style="color:white;">Other symptoms</span>]]
:❑ [[hematuria|<span style="color:white;">hematuria</span>]]
:❑ [[Dysuria|<span style="color:white;">Dysuria</span>]]
:❑ [[Fever|<span style="color:white;">fever</span>]]
:❑ [[low back pain|<span style="color:white;">low back pain</span>]]
:❑ [[neurological symptoms|<span style="color:white;">neurological symptoms</span>]]<br>
❑ [[inquire about recent surgical procedures(patient should void in 6 hours post surgery)|<span style="color:white;">Inquire about recent surgical procedures(patient should void in 6 hours post surgery)</span>]]</div>}}
{{familytree | | | | | | | | | | | | | | | | |!| | | | }}
{{familytree/start}}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | | | | | | | | | | | | | A10 | | | | | A10= <div style="float: left; text-align: left; width: 15em; padding:1em;">'''Physical examination''' <br>
❑ [[Abdominal examination|<span style="color:white;">Abdominal examination</span>]]
:❑ [[Dullness above umbilicus represent 1000 ml urine|<span style="color:white;">Dullness above umbilicus represent 1000 ml urine</span>]]
:❑ [[Dullness just below umbilicus represent about 500 ml of urine|<span style="color:white;">dullness just below umbilicus represent about 500 ml of urine</span>]]<br>
❑ [[Pelvic examination/rectal examination|<span style="color:white;">Pelvic examination/rectal examination</span>]]
:❑ [[Note for enlarged prostate or fecal impaction|<span style="color:white;">Note for enlarged prostate or fecal impaction</span>]]<br>
❑ [[Genital examination|<span style="color:white;">Genital examination</span>]]
:❑ [[poor sphincter tone suggest spinal cord problem|<span style="color:white;">poor sphincter tone suggest spinal cord problem</span>]]<br>
❑ [[Neurological examination|<span style="color:white;">Neurological examination</span>]]
:❑ [[strength|<span style="color:white;">strength</span>]]
:❑ [[sensation|<span style="color:white;">sensation</span>]]
:❑ [[reflexes|<span style="color:white;">reflexes</span>]]
:❑ [[muscle tone|<span style="color:white;">muscle tone</span>]]
</div>}}
{{familytree | | | | | | | | | | | | | | | | |!| | | | }}
{{familytree/start}}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | | | | | A10 | | | | | A10= <div style="float: left; text-align: left; width: 15em; padding:1em;">'''Evaluation''' <br>
❑ [[collect urine sample by placing folley's catheter|<span style="color:white;">collect urine sample by placing folley's catheter</span>]] <br>
❑ [[Perform bladder ultrasound/rectal examination|<span style="color:white;">perform bladder ultrasound</span>]]
:❑ [[check pre and post void residual volume|<span style="color:white;">check pre and post void residual volume</span>]]<br>
❑ [[Complete blood count|<span style="color:white;">Complete blood count</span>]] <br>
❑ [[Chemistry|<span style="color:white;">Chemistry</span>]]
:❑ [[sodium|<span style="color:white;">sodium</span>]]
:❑ [[potassium|<span style="color:white;">potassium</span>]]
:❑ [[bicarbonate|<span style="color:white;">bicarbonate</span>]]
:❑ [[chloride|<span style="color:white;">chloride</span>]]
:❑ [[BUN and creatinine|<span style="color:white;">BUN and creatinine</span>]]
❑ [[urine analysis and culture|<span style="color:white;">urine analysis and culture</span>]] <br>
❑ [[if neurological symptoms-CT head, MRI spine|<span style="color:white;">if neurological symptoms-CT head, MRI spine</span>]] <br>
</div>}}
{{familytree  | | | | | | | | |!| | }}
{{familytree  |boxstyle=background: #FA8072; color: #F8F8FF;| | | | | | | | H01 | | | | | | | | | H01=<div style=" background: #FA8072; text-align: left; width: 20em"> {{fontcolor|#F8F8FF| Volume of urine in first 10-15 minutes of catheterization or with bladder ultrasound?}}</div> }}
{{familytree  | | | | | |,|-|^|-|.|}}
{{familytree  |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | | I01 | | I02 | | I01= <div style=" background: #FA8072; text-align: center; width:20em"> {{fontcolor|#F8F8FF|'''>300ml'''}} </div> | I02=<div style="padding: 5px; background: #FFFFFF; text-align: center;">'''<200 ml'''</div>}}
{{familytree  | | | | | |!| | | |!| | | }}
{{familytree  |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | J01 | | J02 | | J01= <div style=" background: #FA8072; text-align: left; width:20em; padding:1em"> {{fontcolor|#F8F8FF|❑ suggest urinary retention-keep catheter in place if >400 ml|<span style="color:white;">>400 ml</span>]]}} </div> | J02= <div style="padding: 5px; background: #FFFFFF; text-align: center;">'''Urinary retention unlikely''' </div> }}
{{Family tree/end}}
 
==Treatment==
Acute urinary retention is treated with immediate bladder decompression with intermittent urethral catheterization or suprapubic catheterization regardless of the cause and gender. Further management depend upon the cause of retention.<ref name="pmid16986053">{{cite journal| author=Roehrborn CG| title=Acute urinary retention: risks and management. | journal=Rev Urol | year= 2005 | volume= 7 Suppl 4 | issue=  | pages= S31-41 | pmid=16986053 | doi= | pmc=1477606 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16986053  }} </ref>
<ref name="pmid22117624">{{cite journal| author=Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S | display-authors=etal| title=Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. | journal=BJU Int | year= 2012 | volume= 109 | issue= 1 | pages= 88-95 | pmid=22117624 | doi=10.1111/j.1464-410X.2011.10430.x | pmc=3272343 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22117624  }} </ref>
<ref name="pmid19718286">{{cite journal| author=Muruganandham K, Dubey D, Kapoor R| title=Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management. | journal=Indian J Urol | year= 2007 | volume= 23 | issue= 4 | pages= 347-53 | pmid=19718286 | doi=10.4103/0970-1591.35050 | pmc=2721562 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19718286  }} </ref>
<ref name="pmid20877602">{{cite journal| author=Mevcha A, Drake MJ| title=Etiology and management of urinary retention in women. | journal=Indian J Urol | year= 2010 | volume= 26 | issue= 2 | pages= 230-5 | pmid=20877602 | doi=10.4103/0970-1591.65396 | pmc=2938548 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20877602  }} </ref>
 
<span style="font-size:85%">'''Abbreviations:''' '''TwoC:''' [[trial without catheter]]; '''BPH:''' [[Benign prostate hyperplasia]]; '''TURP:''' [[Transurethral resection of prostate]];'''POUR:''' [[postoperative urinary retention]];'''I/V:''' [[Intravenous]]</span>
{{Family tree/start}}
{{familytree | | | | | | | | | A01 | | | | | | | | | A01=<div style="width:25em">'''Management of Acute Urinary retention in Men with benign prostate hyperplasia'''</div><br><div style="width:22em; text-align:left">
</div> }}
{{familytree | | | | | | | | | |!| | | | | | | | | | }}
{{familytree | | | | | | | | | B01 | | |B01=<div style="float: left; text-align: left; width: 18em; padding:1em;">'''Clean intermittent Urethral Self Cathterization''' <br>
</div> }}
{{familytree | | | | | | | |,|-|^|-|.| | | | | | | }}
{{familytree |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | | | A01 | | A02 | | | | |A01={{fontcolor|#F8F8FF|'''successful'''}}| A02=<div style="text-align: center; background: #FFFFFF; height: 25px; line-height: 25px;">'''failed'''</div>}}
{{familytree | | | | | | | |!| | | |!| }}
{{familytree | | | | | | | C03 | | C04 | | | C03=<div style="text-align: left; background: #FA8072; padding:1em;">{{fontcolor|#F8F8FF|'''Admit the patient and give alpha blocker(for example-alfuzosin) plus TwoC for 2 days'''<br>
                  </div>}}|C04= Suprapubic catheterization- Admit if urosepsis, dehydration or signs of renal failure}}
{{familytree | | | | | |,|-|^|-|.| | | | | }}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | C01 | | C02 | | | | | C01=Successful|C02=failed}}
{{familytree | | | | | |!| | | |!| | | }}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | C01 | | C02 | | | | C01=<div style="text-align: left; padding:1em;">'''follow patient with alpha blocker if uncomplicated BPH OR discuss for elective surgery TURP if complicated BPH'''<br> |C02=<div style="text-align: left; padding:1em;">'''recatheterize and discuss TURP'''}}
{{familytree | | | | | |!| | | |!| | | | | }}
{{familytree | | | | | C01 |-|-|'| | | | | C01=<div style="text-align: left; background: #FA8072; padding:1em;">{{fontcolor|#F8F8FF|If recurrent urinary retention-repeat alpha blocker and TwoC|<span style="color:white;">urinary retention</span>]] repeat alpha blocker and TwoC|<span style="color:white;">TwoC</span>]]}}</div>}}
{{Family tree/end}}
 
 


{{familytree/end}}


==Treatment==
Shown below is an algorithm summarizing the treatment of <nowiki>[[disease name]]</nowiki> according the the [...] guidelines.
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree | | | | | | | | A01 |A01= }}  
{{familytree | | | | | | | | | | | | | A01 | | | | | | | |A01=POSTOPERATIVE URINARY RETENTION}}
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
{{familytree | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| }}
{{familytree | | | B01 | | | | | | | | B02 | | |B01= |B02= }}
{{familytree | | | | | B01 | | | | | | | | | | | | | | B02| | |B01=[[Prevention]] |B02=[[Treatment]]}}
{{familytree | | | |!| | | | | | | | | |!| }}
{{familytree | |,|-|-|-|^|-|-|-|.| | | | | | | | | | | |!| }}
{{familytree | | | C01 | | | | | | | | |!| |C01= }}
{{familytree | C01 | | C02 | | C03 | | | | | | | | | | |!| |C01=[[Preoperative]] |C02=[[Intraoperative]] |C03=[[Postoperative]]}}
{{familytree | |,|-|^|.| | | | | | | | |!| }}
{{familytree | |!| | | |!| | | |!| | | | | | | | | | | |!| }}
{{familytree | D01 | | D02 | | | | | | D03 |D01= |D02= |D03= }}
{{familytree | D01 | | D02 | | D03 | | | | | | | | | | D04 |D01=Use of [[alpha blocker]] [[alfuzosin]] if known risk factors e.g [[Diabetes]], [[renal failure]], [[BPH]], elderly age |D02=If using [[I/V]] fluids it is necessary to catheterize to prevent POUR |D03=Early ambulation and judicious use of systemic [[opioids]] can prevent POUR |D04=Catheterization and start [[alpha blocker]] [[tamsulosin]] if not already started}}
{{familytree | |!| | | | | | | | | |,|-|^|.| }}
{{familytree | | | | | | | | | | | | | | | | | | | | | |!| | }}
{{familytree | E01 | | | | | | | E02 | | | E03 |E01= |E02= |E03= }}
{{familytree | | | | | | | | | | | | | | | | | | | | | E01 | E01=TwoC after 1-3 days of [[catheterization]] and if patient fail to void refer to outpatient [[urology]] consultation}}
{{familytree | | | | | | | | | | |!| | | | |!| }}
{{familytree | | | | | | | | | | F01 | | | F02 |F01= |F02= }}
{{familytree/end}}
{{familytree/end}}


==Do's==
==Do's==  
* The content in this section is in bullet points.
 
*Keep a close eye on the patient for [[dehydration]] and [[Metabolic disorders|metabolic abnormalities]] which may result from [[post obstructive diuresis]].
*Perform [[Catheterization|suprapubic catheterization]] in [[patients]] who had recent surgery and it should be [[ultrasound-guided]].
*Admit the [[patient]] with [[Urinary Tract Infections|urosepsis]], [[renal failure]], [[electrolyte imbalance]], [[malignancy]], or [[myelopathy|acute myelopathy]].
*It is must to educate the patient about [[Catheter|catheter care]] and [[Urine output|urine output monitoring]].


==Don'ts==
==Don'ts==
* The content in this section is in bullet points.
 
*Do not perform [[urethral catheterization]] if the patient had a recent urologic surgery such as [[radical prostatectomy]] or [[urethral reconstruction]].
*Do not start [[antibiotics]] until an [[infection]] is confirmed.
 


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Help]]
[[Category:Projects]]
[[Category:Resident survival guide]]
[[Category:Resident survival guide]]
[[Category:Templates]]
[[Category:Up-To-Date]]
 
[[Category:Urology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 13:24, 15 April 2021


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kanwal Khamuani

Urinary retention Resident Survival Guide Microchapters
Overview
Causes
Urinary retention in women
Urinary Retention in Men
Diagnosis
Treatment
Do's
Don'ts

Synonyms and keywords:

Overview

Urinary retention is defined as an inability to pass urine, or incomplete emptying of the bladder. It is one of the most common presenting complaints encountered in the emergency department, and can be acute or chronic. It is commonly seen in males as compared to females due to benign prostate hyperplasia. If undiagnosed or left untreated, this condition can be life-threatening as it may lead to kidney damage and severe urosepsis. Acute urinary retention can be extremely uncomfortable, and is initially managed by urethral or suprapubic catheterization. Chronic urinary retention is often asymptomatic, not easily identified, and is linked to increased post void residual volume. A complete detailed history about current prescription, over the counter and herbal medications is necessary along with focused physical examination that must include neurological evaluation.

Causes

Urinary Retention in Women

Urinary retention is overall very rare in women and can be acute or chronic. Common causes include: [1]

Urinary Retention in Men

Urinary retention is more common in males, with a male to female ratio of 13:1.

Causes of Acute urinary retention in men
❑ Obstructive causes

Benign Prostate Hyperplasia
Prostate or Bladder Carcinoma
Constipation
Urolithiasis
Urethral Stricture
Phimosis or Paraphimosis

❑ Infectious Causes

Prostatitis
Urethritis
Genital herpes

❑ Neurological Causes

stroke
spinal cord injury
Demyelinating disorders-Guillain barre syndrome, diabetic neuropathy, Multiple sclerosis.

Detrusor Muscle Dysfunction
❑ Medications

Sympathomimetic alpha adrenergic agents-Phenylephrine
Sympathomimetic beta adrenergic agents-Isoproterenol
Antidepressants-Amitriptyline,Imipramine
Antiarrhythmics-Quinidine, procainamide, Disopyramide
Anticholinergics-Atropine, oxybutynin, glycopyrrolate
Antiparkinsonian agents-Amantadine, trihexyphenidyl,levadopa, bromocriptine
Antipsychotics-Haloperidol, fluphenazine
Hormonal agents-estrogen, progesterone, testosterone
Antihistamines-diphenhydramine, hydroxysine
Antihypertensives-Hydralazine,nifedipine
❑ Others-indomethacin, morphine, dopamine, amphetamines

Causes of Chronic urinary retention in Men
❑ Neurological Causes

Diabetic neuropathy
peripheral neuropathy
Spinal injury

Detrusor Muscle Dysfunction

Diagnosis

A detailed history and a thorough physical examination may help in diagnosing the cause behind urinary retention.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Volume of urine in first 10-15 minutes of catheterization or with bladder ultrasound?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>300ml
 
<200 ml
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ suggest urinary retention-keep catheter in place if >400 ml
 
Urinary retention unlikely
 

Treatment

Acute urinary retention is treated with immediate bladder decompression with intermittent urethral catheterization or suprapubic catheterization regardless of the cause and gender. Further management depend upon the cause of retention.[3] [4] [5] [2]

Abbreviations: TwoC: trial without catheter; BPH: Benign prostate hyperplasia; TURP: Transurethral resection of prostate;POUR: postoperative urinary retention;I/V: Intravenous

 
 
 
 
 
 
 
 
Management of Acute Urinary retention in Men with benign prostate hyperplasia

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clean intermittent Urethral Self Cathterization
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
successful
 
failed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit the patient and give alpha blocker(for example-alfuzosin) plus TwoC for 2 days
 
Suprapubic catheterization- Admit if urosepsis, dehydration or signs of renal failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Successful
 
failed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
follow patient with alpha blocker if uncomplicated BPH OR discuss for elective surgery TURP if complicated BPH
 
recatheterize and discuss TURP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If recurrent urinary retention-repeat alpha blocker and TwoC
 
 
 
 
 
 
 
 
 
 
 



 
 
 
 
 
 
 
 
 
 
 
 
POSTOPERATIVE URINARY RETENTION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prevention
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preoperative
 
Intraoperative
 
Postoperative
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Use of alpha blocker alfuzosin if known risk factors e.g Diabetes, renal failure, BPH, elderly age
 
If using I/V fluids it is necessary to catheterize to prevent POUR
 
Early ambulation and judicious use of systemic opioids can prevent POUR
 
 
 
 
 
 
 
 
 
Catheterization and start alpha blocker tamsulosin if not already started
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TwoC after 1-3 days of catheterization and if patient fail to void refer to outpatient urology consultation

Do's

Don'ts


References

  1. Serlin DC, Heidelbaugh JJ, Stoffel JT (2018). "Urinary Retention in Adults: Evaluation and Initial Management". Am Fam Physician. 98 (8): 496–503. PMID 30277739.
  2. 2.0 2.1 Mevcha A, Drake MJ (2010). "Etiology and management of urinary retention in women". Indian J Urol. 26 (2): 230–5. doi:10.4103/0970-1591.65396. PMC 2938548. PMID 20877602.
  3. Roehrborn CG (2005). "Acute urinary retention: risks and management". Rev Urol. 7 Suppl 4: S31–41. PMC 1477606. PMID 16986053.
  4. Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S; et al. (2012). "Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia". BJU Int. 109 (1): 88–95. doi:10.1111/j.1464-410X.2011.10430.x. PMC 3272343. PMID 22117624.
  5. Muruganandham K, Dubey D, Kapoor R (2007). "Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management". Indian J Urol. 23 (4): 347–53. doi:10.4103/0970-1591.35050. PMC 2721562. PMID 19718286.